Current Report Filing (8-k)
June 23 2023 - 3:02PM
Edgar (US Regulatory)
0001689657
false
0001689657
2023-06-21
2023-06-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
June 21, 2023
Date of Report (Date of earliest event reported)
PhenomeX Inc.
(Exact name of registrant as specified in its
charter)
Delaware |
|
35-2415390 |
(State or other jurisdiction
of incorporation) |
|
(I.R.S. Employer
Identification No.) |
001-39388
(Commission File Number)
|
|
|
5858 Horton Street, Suite 320 |
|
|
Emeryville, California |
|
94608 |
(Address of principal executive offices) |
|
(Zip Code) |
(510) 858-2855
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
symbol(s) |
|
Name of each exchange
on which registered |
Common stock, $0.00005 par value |
|
CELL |
|
The Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing
On June 21, 2023, PhenomeX Inc. (the “Company”) received
a notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s
Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”), because the minimum bid price of the Company’s common stock
has been below $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the listing or trading of the Company’s
common stock on The Nasdaq Global Select Market.
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has
180 calendar days, or until December 12, 2023, to regain compliance with the Minimum Bid Price Rule. To regain compliance, the closing
bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days during this
180 calendar day grace period, unless Nasdaq exercises its discretion to extend this ten-day period pursuant
to Nasdaq Listing Rule 5810(c)(3)(H).
In the event the Company does not regain compliance with the
Minimum Bid Price Rule by December 12, 2023, the Company may be eligible for an additional 180 calendar day compliance period if it
elects to transfer to The Nasdaq Capital Market. To qualify, the Company would be required to meet the continued listing requirement
for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception
of the Minimum Bid Price Rule, and would need to provide written notice of its intention to cure the bid price deficiency during the
second compliance period. However, if it appears to Nasdaq’s staff that the Company will not be able to cure the deficiency or
if the Company is otherwise not eligible, or if the Company’s common stock has a closing bid price of $0.10 or less for ten
consecutive trading days during any such compliance period, Nasdaq would notify the Company that its common stock would be subject
to delisting. The Company may appeal any such determination to delist its common stock, but there can be no assurance that any such
appeal would be successful.
There can be no assurance that the Company
will regain compliance with the Minimum Bid Price Rule or otherwise maintain compliance with any of the other listing requirements. Nonetheless,
the Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options, including
a reverse stock split, to regain compliance with the Minimum Bid Price Rule.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 23, 2023 |
PhenomeX Inc. |
|
|
|
|
By: |
/s/ Scott Chaplin |
|
|
Scott Chaplin |
|
|
Chief Legal Officer |
Berkeley Lights (NASDAQ:BLI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Berkeley Lights (NASDAQ:BLI)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Berkeley Lights Inc (NASDAQ): 0 recent articles
More Phenomex Inc. News Articles